Adaptive Self-Efficacy-Based AI Coaching for Cycling (AI)

February 27, 2026 updated by: Anna Queiroz, University of Miami

Adaptive Self-Efficacy-Based AI Coaching for Enhanced Indoor Cycling Performance: A Personalized Machine Learning Approach

The primary objective of this study is to evaluate whether adaptive, AI-delivered personalized self-efficacy-based AI coaching based on real-time physiological and performance feedback enhance indoor cycling power output during a 20-minute time trial compared to static affirmations and exercise-only control conditions.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Meshak Cole, B.S.
  • Phone Number: 305-284-3752
  • Email: mwc94@miami.edu

Study Locations

    • Florida
      • Coral Gables, Florida, United States, 33146
        • University of Miami
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18-40 years

    • Recreationally active
    • Familiar with stationary cycling
    • Able to complete 20 minutes of vigorous cycling

Exclusion Criteria:

  • Cardiovascular, metabolic, or respiratory conditions

    • Medications affecting heart rate response
    • Lower extremity injury within past 3 months
    • Competitive cyclists (>10 hours cycling/week)
    • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
No affirmations delivered. Participants receive only time notifications at 5, 10, 15, and 19 minutes for pacing awareness. Same equipment worn to control for potential monitoring effects.
Experimental: Group 1: Self-efficacy-based AI coaching
The Thompson Sampling contextual bandit algorithm, trained on Session 1 data, monitors performance continuously and evaluates every 5 seconds whether to deliver an affirmation.

The Thompson Sampling contextual bandit algorithm, trained on Session 1 data, monitors performance continuously and evaluates every 5 seconds whether to deliver an affirmation. The policy is trained to maximize a multi-objective "efficacy-preserving performance" function that rewards:

  • Maintaining target power relative to rolling 30s/2min/5min baselines
  • Stabilizing short-horizon power variability (30s coefficient of variation)
  • Stabilizing heart-rate (HR) trajectory consistent with efficient pacing

The decision process considers:

  • Current power relative to 30-second, 2-minute, and 5-minute rolling averages
  • Power output variability (coefficient of variation over past 30 seconds)
  • Heart rate trajectory and cardiac drift patterns
  • Cadence stability and changes from baseline
  • Time elapsed and expected fatigue progression based on power-duration curve Self-efficacy-based AI coaching adapts to physiological measures (power and heart rate).
Active Comparator: Group 2: Static AI Affirmations
Generic motivational messages delivered at fixed intervals (minutes 3, 6, 9, 12, 15, and 18) regardless of performance state. Messages follow the same complexity gradient based on elapsed time rather than individual response.

Generic motivational messages delivered at fixed intervals (minutes 3, 6, 9, 12, 15, and 18) regardless of performance state. Messages follow the same complexity gradient based on elapsed time rather than individual response:

  • Minutes 3, 6: "You're building momentum with every pedal stroke-maintain this strong rhythm"
  • Minutes 9, 12: "Strong effort-push through this challenge"
  • Minutes 15, 18: "Final push-finish strong"

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean cycling power output during 20-minute time trial
Time Frame: Day 2
Average cycling power output over the full 20-minute time trial. The outcome compares mean power between intervention arms (adaptive AI coaching vs. static affirmations vs. exercise-only control). Power is captured continuously via the cycling ergometer and summarized as the mean watts for each participant's trial.
Day 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Queiroz, Ph.D., University of Miami

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 23, 2028

Study Completion (Estimated)

December 28, 2028

Study Registration Dates

First Submitted

December 19, 2025

First Submitted That Met QC Criteria

December 22, 2025

First Posted (Actual)

January 5, 2026

Study Record Updates

Last Update Posted (Actual)

March 3, 2026

Last Update Submitted That Met QC Criteria

February 27, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20251354

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Training

Clinical Trials on Group 1: Self-efficacy-based AI coaching

Subscribe